Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders

Agmatine and agmatine analogs in the treatment of epilepsy, seizure, and electroconvulsive disorders

US Patent 7816407 · Granted Oct 19, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cellulose based anti-viral anti-microbial spray coating2025
Vesicular monoamine transporter-2 ligands and their use in the treatment of psyc2024
Tempo-cellulose structures and related methods2024
Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use the2022
Nanoparticle-induced fusogenicity between liposome and endosome membranes for ta2022
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2022
Dehydroleucodine derivatives and uses thereof2021
Diindole compounds useful in treatment of nervous system disorders2021
Vesicular monoamine transporter-2 ligands and their use in the treatment of psyc2020
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2020
Diindole compounds useful in treatment of nervous system disorders2019
Triazole derivatives of melampomagnolide B and methods of use thereof2019